175 related articles for article (PubMed ID: 3494081)
1. Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes.
Dijkstra J; Mellors JW; Ryan JL; Szoka FC
J Immunol; 1987 Apr; 138(8):2663-70. PubMed ID: 3494081
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of liposome-incorporation on liver macrophage activating potencies of rough lipopolysaccharide, lipid A, and muramyl dipeptide. Differences in susceptibility to lysosomal enzymes.
Daemen T; Veninga A; Dijkstra J; Scherphof G
J Immunol; 1989 Apr; 142(7):2469-74. PubMed ID: 2926140
[TBL] [Abstract][Full Text] [Related]
3. Altered in vivo activity of liposome-incorporated lipopolysaccharide and lipid A.
Dijkstra J; Mellors JW; Ryan JL
Infect Immun; 1989 Nov; 57(11):3357-63. PubMed ID: 2807528
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
[TBL] [Abstract][Full Text] [Related]
5. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
Daemen T; Veninga A; Roerdink FH; Scherphof GL
Cancer Res; 1986 Sep; 46(9):4330-5. PubMed ID: 3731091
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 1 release by human monocytes treated with liposome-encapsulated lipopolysaccharide.
Bakouche O; Koff WC; Brown DC; Lachman LB
J Immunol; 1987 Aug; 139(4):1120-6. PubMed ID: 3497194
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of LPS in liposomes diminishes its ability to induce tumoricidal activity and tumor necrosis factor secretion in murine macrophages.
Dijkstra J; Larrick JW; Ryan JL; Szoka FC
J Leukoc Biol; 1988 May; 43(5):436-44. PubMed ID: 3131472
[TBL] [Abstract][Full Text] [Related]
8. A procedure for the efficient incorporation of wild-type lipopolysaccharide into liposomes for use in immunological studies.
Dijkstra J; Ryan JL; Szoka FC
J Immunol Methods; 1988 Nov; 114(1-2):197-205. PubMed ID: 3263442
[TBL] [Abstract][Full Text] [Related]
9. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
Schroit AJ; Fidler IJ
Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
[TBL] [Abstract][Full Text] [Related]
10. Activation of murine lymphocytes by lipopolysaccharide incorporated in fusogenic, reconstituted influenza virus envelopes (virosomes).
Dijkstra J; Bron R; Wilschut J; de Haan A; Ryan JL
J Immunol; 1996 Aug; 157(3):1028-36. PubMed ID: 8757606
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of lymphokine-induced macrophage microbicidal activity against Leishmania major by liposomes: characterization of the physicochemical requirements for liposome inhibition.
Gilbreath MJ; Hoover DL; Alving CR; Swartz GM; Meltzer MS
J Immunol; 1986 Sep; 137(5):1681-7. PubMed ID: 3745916
[TBL] [Abstract][Full Text] [Related]
12. Encapsulation is not involved in the activities of recombinant gamma interferon associated with multilamellar phospholipid liposomes on murine bone marrow-derived macrophages.
Hume DA; Nayar R
Lymphokine Res; 1989; 8(4):415-25. PubMed ID: 2509821
[TBL] [Abstract][Full Text] [Related]
13. In vitro interaction of L1210 cells with phospholipid vesicles.
Jansons VK; Weis P; Chen T; Redwood WR
Cancer Res; 1978 Mar; 38(3):530-5. PubMed ID: 564235
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of phagocytosis in bone marrow-derived mouse macrophages by bacterial lipopolysaccharide: correlation with biochemical and functional parameters.
Cooper PH; Mayer P; Baggiolini M
J Immunol; 1984 Aug; 133(2):913-22. PubMed ID: 6736651
[TBL] [Abstract][Full Text] [Related]
15. Novel cationic liposome formulation for the delivery of an oligonucleotide decoy to NF-kappaB into activated macrophages.
De Rosa G; De Stefano D; Laguardia V; Arpicco S; Simeon V; Carnuccio R; Fattal E
Eur J Pharm Biopharm; 2008 Sep; 70(1):7-18. PubMed ID: 18482831
[TBL] [Abstract][Full Text] [Related]
16. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin.
Brandenburg K; Jürgens G; Müller M; Fukuoka S; Koch MH
Biol Chem; 2001 Aug; 382(8):1215-25. PubMed ID: 11592403
[TBL] [Abstract][Full Text] [Related]
17. Interactions of lipid a and liposome-associated lipid A with Limulus polyphemus amoebocytes.
Richardson EC; Banerji B; Seid RC; Levin J; Alving CR
Infect Immun; 1983 Mar; 39(3):1385-91. PubMed ID: 6840843
[TBL] [Abstract][Full Text] [Related]
18. Chemically detoxified lipid A precursor derivatives antagonize the TNF-alpha-inducing action of LPS in both murine macrophages and a human macrophage cell line.
Tanamoto K
J Immunol; 1995 Dec; 155(11):5391-6. PubMed ID: 7594555
[TBL] [Abstract][Full Text] [Related]
19. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
